FDA grants Breakthrough Therapy Designation to Usona Institute's psilocybin program for major depressive disorder
November 22, 2019
Usona Institute PSIL201 Study Site Now Recruiting Patients with Depression
October 24, 2019
Usona Institute Clinical Trial of Psilocybin for Major Depressive Disorder Launching This Fall
September 5, 2019
